Cetuximab Monotherapy Maintenance Treatment in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)
- Status
- COMPLETED
- Phase
- PHASE1
Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab
- Status
- COMPLETED
- Phase
- PHASE3
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
- Status
- UNKNOWN
- Phase
- PHASE1